These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 8237828
1. Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Implications for antiarrhythmic effects of class III drugs. Wit AL, Coromilas J. Am J Cardiol; 1993 Nov 26; 72(16):3F-12F. PubMed ID: 8237828 [Abstract] [Full Text] [Related]
2. Role of wavelength adaptation in the initiation, maintenance, and pharmacologic suppression of reentry. Girouard SD, Rosenbaum DS. J Cardiovasc Electrophysiol; 2001 Jun 26; 12(6):697-707. PubMed ID: 11405405 [Abstract] [Full Text] [Related]
3. Symposium on the management of ventricular dysrhythmias. Concept of reentry versus automaticity. Sasyniuk BI. Am J Cardiol; 1984 Jul 30; 54(2):1A-6A. PubMed ID: 6380258 [Abstract] [Full Text] [Related]
4. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Coromilas J, Saltman AE, Waldecker B, Dillon SM, Wit AL. Circulation; 1995 Apr 15; 91(8):2245-63. PubMed ID: 7697855 [Abstract] [Full Text] [Related]
5. The cardiac vulnerable period and reentrant arrhythmias: targets of anti- and proarrhythmic processes. Starmer CF. Pacing Clin Electrophysiol; 1997 Feb 15; 20(2 Pt 2):445-54. PubMed ID: 9058848 [Abstract] [Full Text] [Related]
13. Importance of location and timing of electrical stimuli in terminating sustained functional reentry in isolated swine ventricular tissues: evidence in support of a small reentrant circuit. Kamjoo K, Uchida T, Ikeda T, Fishbein MC, Garfinkel A, Weiss JN, Karagueuzian HS, Chen PS. Circulation; 1997 Sep 16; 96(6):2048-60. PubMed ID: 9323098 [Abstract] [Full Text] [Related]
14. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Sep 16; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
16. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Circulation; 1993 Sep 16; 88(3):1030-44. PubMed ID: 8353865 [Abstract] [Full Text] [Related]
17. Computer simulation of the reentrant cardiac arrhythmias in ischemic myocardium. Zhang H, Yang L, Jin YB, Zhang ZX, Huang YZ. Chin J Physiol; 2005 Sep 30; 48(3):155-9. PubMed ID: 16304842 [Abstract] [Full Text] [Related]
18. Systematic characterization of the reentrant circuit during atrioventricular nodal reentrant tachycardia. Monahan KM, Zebede J, Josephson ME, Schuger CD. Am J Cardiol; 1995 Jul 15; 76(3):138-43. PubMed ID: 7611147 [Abstract] [Full Text] [Related]
19. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects]. Steinbeck G. Z Kardiol; 1992 Jul 15; 81 Suppl 4():139-43. PubMed ID: 1290290 [Abstract] [Full Text] [Related]
20. Reflections on reentry and focal activity. Janse MJ, D'Alnoncourt CN. Am J Cardiol; 1987 Oct 16; 60(11):21F-26F. PubMed ID: 3310581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]